Do drugs of abuse impact on HIV disease?

Journal of Neuroimmunology

Volumn 147, Issue 1-2, 2004, Pages 6-8

  Khalsa, Jag H ^a   Royal III, Walter ^b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Disease progression; Drug abuse; HIV AIDS

Indexed keywords

COCAINE; ILLICIT DRUG; METHAMPHETAMINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADDICTION; CONFERENCE PAPER; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG ABUSE; EPIDEMIOLOGICAL DATA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFESTYLE; NEUROTOXICITY; PATHOLOGY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RISK FACTOR;

EID: 1642493600     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.10.007     Document Type: Conference Paper

References (12)

1. Andersen S.N., Skullerud K. Hypoxic/ischemic brain damage, especially pallidal lesions, in heroin addicts. Forensic Sci. Int. 102:1999;51-59.
2. Anderson E., Zink W., Xiong H., Gendelman H.E. HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J. Acquir. Immune. Defic. Syndr. 31(Suppl. 2):2002;S43-S54.
3. Bell J.E., Brettle R.P., Chiswick A., Simmonds P. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain. 121(Pt. 11):1998;2043-2052.
4. Centers for Disease Control HIV/AIDS Surveillance Report. vol. 13:2001;14.
5. Chang L., Ernst T., Strickland T., Mehringer C.M. Gender effects on persistent cerebral metabolite changes in the frontal lobes of abstinent cocaine users. Am. J. Psychiatry. 156(5):1999;716-722.
6. Cocchi F., DeVico A.L., Garzino-Demo A., Arya S.K., Gallo R.C., Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science. 270:1995;1811-1815.
7. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R., O'Brien S.J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene, Hemophilia growth and development study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science. 273(5283):1996;1856-1862.
8. Gayle H.D. An overview of the global HIV/AIDS epidemic, with a focus on the United States. AIDS. 14:2000;S8-S17. (Suppl.).
9. Gayle H.D., Hill G.L. Global impact of human immunodeficiency virus and AIDS. Clin. Microbiol. Rev. 14:2001;327-335.
10. Substance Abuse and Mental Health Services Administration National Household Survey on Drug Abuse: Main Findings. 2002;U.S. Department of Health and Human Services, Rockville, MD.
11. WHO/UNAIDS, 2001. AIDS Epidemic Update 2001. UNAIDS (Joint United Nations Programme on HIV/AIDS).
12. Zhang L., Yu W., He T., Yu J., Caffrey R.E., Dalmasso E.A., Fu S., Pham T., Mei J., Ho J.J., Zhang W., Lopez P., Ho D.D. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science. 298(5595):2002;995-1000.